AstraZeneca SG signs MOU with tech partners

The partnerships aim to improve care delivery and patient outcomes.

AstraZeneca Singapore signed a memorandum of understanding (MOU) with tech partners Respiree, OncoShot, Thermaiscan, Ubie and Hewlett Packard Enterprise on 25 November. The partnerships aim to pilot data and artificial intelligence-driven projects in Singapore to drive healthcare improvement.

"AstraZeneca's A.Catalyst Network brings together partners across the public and private sectors to unlock the power of innovation and transform care delivery for improved patient experience and outcomes", said country president Vinod Narayanan. "Facilitating such partnerships will drive improvement in the healthcare ecosystem while providing patients with access to new digital healthcare solutions that can revolutionise the management of challenging diseases such as cancer, diabetes, heart failure and respiratory diseases."

The partnership was witnessed by Singapore's Ministry of Health, the Government Offices of Sweden, the Embassy of Sweden in Singapore, and Business Sweden.